🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
0.8760
-0.4340 (-33.13%)
At close: Nov 20, 2026, 4:00 PM EST
0.8620
-0.0140 (-1.60%)
After-hours: Nov 20, 2026, 7:40 PM EST

PMV Pharmaceuticals Statistics

Total Valuation

PMVP has a market cap or net worth of $66.17 million. The enterprise value is -$42.21 million.

Market Cap66.17M
Enterprise Value -42.21M

Important Dates

The last earnings date was Tuesday, November 10, 2026, before market open.

Earnings Date Nov 10, 2026
Ex-Dividend Date n/a

Share Statistics

PMVP has 75.53 million shares outstanding. The number of shares has increased by 8.38% in one year.

Current Share Class 75.53M
Shares Outstanding 75.53M
Shares Change (YoY) +8.38%
Shares Change (QoQ) +24.06%
Owned by Insiders (%) 2.38%
Owned by Institutions (%) 55.63%
Float 59.17M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.16
P/TBV Ratio 1.16
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 9.81, with a Debt / Equity ratio of 0.00.

Current Ratio 9.81
Quick Ratio 9.59
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -99.42% and return on invested capital (ROIC) is -53.86%.

Return on Equity (ROE) -99.42%
Return on Assets (ROA) -72.20%
Return on Invested Capital (ROIC) -53.86%
Return on Capital Employed (ROCE) -76.66%
Weighted Average Cost of Capital (WACC) 12.55%
Revenue Per Employee n/a
Profits Per Employee -$1.64M
Employee Count54
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, PMVP has paid $22,000 in taxes.

Income Tax 22,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -35.59% in the last 52 weeks. The beta is 1.51, so PMVP's price volatility has been higher than the market average.

Beta (5Y) 1.51
52-Week Price Change -35.59%
50-Day Moving Average 1.37
200-Day Moving Average 1.31
Relative Strength Index (RSI) 31.45
Average Volume (20 Days) 712,081

Short Selling Information

The latest short interest is 2.15 million, so 2.85% of the outstanding shares have been sold short.

Short Interest 2.15M
Short Previous Month 2.29M
Short % of Shares Out 2.85%
Short % of Float 3.64%
Short Ratio (days to cover) 2.70

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -77.21M
Pretax Income -88.51M
Net Income -88.53M
EBITDA -77.09M
EBIT -77.21M
Earnings Per Share (EPS) -$1.56
Full Income Statement

Balance Sheet

The company has $108.52 million in cash and investments and $138,000 in debt, with a net cash position of $108.38 million or $1.43 per share.

Cash & Investments 108.52M
Total Debt 138,000
Net Cash 108.38M
Net Cash Per Share $1.43
Equity (Book Value) 57.11M
Book Value Per Share 0.76
Working Capital 94.21M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$69.63 million and capital expenditures -$15,000, giving a free cash flow of -$69.64 million.

Operating Cash Flow -69.63M
Capital Expenditures -15,000
Depreciation & Amortization 114,000
Net Borrowing n/a
Free Cash Flow -69.64M
FCF Per Share -$0.92
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

PMVP does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -8.38%
Shareholder Yield -8.38%
Earnings Yield -178.65%
FCF Yield -105.25%

Analyst Forecast

The average price target for PMVP is $4.00, which is 356.62% higher than the current price. The consensus rating is "Strong Buy".

Price Target $4.00
Price Target Difference 356.62%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1